Compensatory glutamine metabolism induced by cancer therapies suggests that targeting glutamine metabolism may be used in combination therapy
Qualifying conditions include type 2 diabetes, prediabetes, high blood pressure, high cholesterol, sleep apnea, PCOS, fatty liver disease, cardiovascular disease, insulin resistance, metabolic syndrome, and weight-related joint pain
Patients experiencing sustained fatigue or plateauing weight loss after 8 to 12 weeks may benefit from increasing Lipo C to 2 mL weekly, while those reporting stable energy and consistent progress can maintain lower doses
Through the combined application of genetic engineering, synthetic biology, and nanotechnology, we aim to clarify the optimization strategies of engineered live bacteria